Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Eli Lilly and Company
Woman and Man
Between 18 years
and 99 years
Eli Lilly and Company
Update Il y a 6 ans
Etude monarchE : étude de phase 3, randomisée, visant à évaluer l’abemaciclib associé à une hormonothérapie adjuvante standard comparé à une hormonothérapie adjuvante standard seule chez des patients ayant un cancer du sein de stade précoce mais de risque élevé, avec extension du cancer au niveau des ganglions, positif au récepteur hormonal (RH+) mais négatif au récepteur HER2 (HER2-).
Le cancer du sein est le cancer le plus fréquent chez la femme. 30 % des cancer du sein peuvent devenir métastatique, c’est-à-dire que les cellules cancéreuses peuvent se propager à d’autres parties d...
Country
France
organs
Sein
Specialty
Thérapies Ciblées
,
Hormonothérapie
Essai ouvert aux inclusions
More information
Man Max 99 years
Eli Lilly and Company
Update Il y a 4 ans
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Global Multicenter Study to Evaluate the Efficacy and Safety of Tadalafil Once Daily Dosing for 12 Weeks in Men with Signs and Symptoms of Benign Prostatic Hyperplasia
To evaluate the efficacy of tadalafil 5 mg once daily for 12 weeks compared with placebo in improving the IPSS in men with signs and symptoms of BPH, also referred to as BPH-LUTS (lower urinary tract ...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Eli Lilly and Company Limited
Update Il y a 4 ans
A Randomized, Controlled, Open-Label Study of the Long-Term Impact on Functioning using Atomoxetine Hydrochloride Compared to Other Early Standard Care in the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in Treatment-Naïve Children and Adolescents. (ADHD-LIFE Study)
The primary objective is to test the hypothesis that atomoxetine given at individually titrated doses for 6 months is superior to other early standard therapy in improving quality of life as measured ...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Eli Lilly and Company
Update Il y a 4 ans
A Study in Patients With Cluster Headache
To evaluate the safety of open-label galcanezumab within the context of dosing during expected medical practice in eligible patients with episodic or chronic cluster headache.
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man
Between 18 years
and 99 years
Eli Lilly and Company
Update Il y a 6 ans
Étude RELAY : étude de phase 3 randomisée comparant la sécurité et l’efficacité du ramucirumab associé à l’erlotinib au placebo associé à l’erlotinib chez des patients ayant un cancer du poumon non à petites cellules avec l’EGFR muté et métastatique non-traité antérieurement.
Le cancer de poumon non à petites cellules est le type de cancer de poumon le plus fréquent, il représente 85-90% de l’ensemble des cancers de poumon. Le cancer du poumon non à petites cellules métast...
Country
France
organs
Poumon, type non à petites cellules
Specialty
Thérapies Ciblées
,
Immunothérapie - Vaccinothérapie
Essai ouvert aux inclusions
More information
Woman and Man Max 99 years
Eli Lilly and Company
Update Il y a 4 ans
Effect of Duloxetine 60 mg Once Daily versus Placebo in Patients with Chronic Low Back Pain
To assess the efficacy of duloxetine 60 mg once daily (QD) compared with placebo on the reduction of pain severity as measured by the Brief Pain Inventory (BPI) 24-hour average pain score ( in patient...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Eli Lilly and Company
Update Il y a 4 ans
A clinical trial looking at the use and safety of tadalafil for the treatment of pulmonary arterial hypertension in children
Period 1 primary objectives: For the EU regulatory assessment, the primary objective of Period 1 is to evaluate the efficacy of tadalafil compared with placebo, as measured by time to clinical wor...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Eli Lilly and Company Ltd
Update Il y a 4 ans
Effect of Duloxetine 60 mg to 120 mg Once Daily in Patients with Chronic Low Back Pain
The primary objective of this study is to assess the efficacy of duloxetine 60 mg once daily (QD) to 120 mg QD compared with placebo on the reduction of pain severity as measured by the weekly mean of...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Eli Lilly and Company Limited
Update Il y a 4 ans
A Trial Comparing Two Therapies: Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects With Type 2 Diabetes
To estimate the difference in change in HbA1c from the randomization visit (visit 2) to endpoint (30 weeks) between 2 regimens: BET (basal insulin Glargine, Exenatide BID and metformin) and BBT (basal...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman Max 99 years
Eli Lilly and Company
Update Il y a 4 ans
A Phase 2 Neoadjuvant Study of Abemaciclib (LY2835219) in Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Breast Cancer (neoMONARCH)
To compare the biological activity of abemaciclib in combination with anastrozole, abemaciclib monotherapy, and anastrozole monotherapy by assessing the percentage change from the baseline value in K...
Country
None
organs
None
Specialty
None
unknown
More information
Previous
1
2
3
4
5
6
7
8
9
10
Next